Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;132(3):393-400.
doi: 10.1016/j.clim.2009.05.017. Epub 2009 Jul 2.

Comprehensive seroprofiling of sixteen B. burgdorferi OspC: implications for Lyme disease diagnostics design

Affiliations

Comprehensive seroprofiling of sixteen B. burgdorferi OspC: implications for Lyme disease diagnostics design

Larisa Ivanova et al. Clin Immunol. 2009 Sep.

Abstract

Early diagnosis of Lyme disease (LD) is critical to successful treatment. However, current serodiagnostic tests do not reliably detect antibodies during early infection. OspC induces a potent early immune response and is also one of the most diverse proteins in the Borrelia proteome. Yet, at least 70% of the amino acid sequence is conserved among all 21 known OspC types. We performed a series of comprehensive seroprofiling studies to select the OspC types that have the most cross-reactive immunodominant epitopes. We found that proteins belonging to seven OspC types detect antibodies from all three infected host species regardless of the OspC genotype of the infecting strain. Although no one OspC type identifies all seropositive human samples, combinations of as few as two OspC proteins identified all patients that had anti-OspC antibodies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
OspC seroprofiling of laboratory infected mice. ELISA immunoarrays of five rOspC proteins detect anti-OspC antibodies in all infected mice, regardless of the OspC-type of the B. burgdorferi with which the mouse was infected. All other rOspC proteins failed to detect anti-OspC antibodies from at least one B. burgdorferi-infected mouse (i.e. rOspC-type A did not detect mice infected with B. burgdorferi strains having either OspC-type D or M). Anti-mouse IgG HRP secondary antibody was used. ELISA readings below the detection cutoff (negative) have been highlighted in red.
Figure 2
Figure 2
Variation among naturally-infected white-footed mice in the amount of antibodies detected by each rOspC protein. Each graph represents the frequency distribution of OD values obtained from the reaction of IgG in serum from naturally-infected white-footed mice (P. leucopus) to each type-specific-rOspC protein by ELISA. Serum panel tested positive for B. burgdorferi infection by the C6 ELISA assay.
Figure 3
Figure 3
Variation among naturally-infected dogs in the amount of antibodies detected by each rOspC protein. Each graph represents the frequency distribution of OD values obtained from the reaction of IgG in serum from naturally-infected dogs (Canis lupus familiaris) to each type-specific-rOspC protein by ELISA. Serum panel tested positive for B. burgdorferi infection by the whole cell sonicate ELISA assay.
Figure 4
Figure 4
Variation among naturally-infected humans from North America in the amount of antibodies detected by each rOspC protein. Each graph represents the frequency distribution of OD values obtained from the reaction of IgG in serum from naturally-infected humans (Homo sapiens) to each type-specific-rOspC protein by ELISA. Serum panel tested positive for B. burgdorferi infection by the C6 ELISA assay.
Figure 5
Figure 5
Variation among naturally-infected humans from Europe in the amount of antibodies detected by each rOspC protein. Each graph represents the frequency distribution of OD values obtained from the reaction of IgG in serum from naturally-infected humans (Homo sapiens) to each type-specific-rOspC protein by ELISA. Serum panel tested positive for B. burgdorferi infection by the whole cell sonicate ELISA assay.

References

    1. Bratton RL, Whiteside JW, Hovan MJ, Engle RL, Edwards FD. Diagnosis and treatment of Lyme disease. Mayo Clin Proc. 2008;83:566–571. - PubMed
    1. Plorer A, Sepp N, Schmutzhard E, Krabichler S, Trobos S, Schauer G, Pahl C, Stoffler G, Fritsch P. Effects of adequate versus inadequate treatment of cutaneous manifestations of Lyme borreliosis on the incidence of late complications and late serologic status. J Invest Dermatol. 1993;100:103–109. - PubMed
    1. Smith RP. Current diagnosis and treatment of lyme disease. Compr Ther. 2005;31:284–290. - PubMed
    1. Baranton G, Seinost G, Theodore G, Postic D, Dykhuizen D. Distinct levels of genetic diversity of Borrelia burgdorferi are associated with different aspects of pathogenicity. Res Microbiol. 2001;152:149–156. - PubMed
    1. Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol. 1999;37:3990–3996. - PMC - PubMed

Publication types

MeSH terms